KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Cash from Financing Activities (2018 - 2025)

ClearPoint Neuro (CLPT) has disclosed Cash from Financing Activities for 12 consecutive years, with $19.6 million as the latest value for Q4 2025.

  • Quarterly Cash from Financing Activities rose 52775.68% to $19.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $50.2 million through Dec 2025, up 710.78% year-over-year, with the annual reading at $50.2 million for FY2025, 710.78% up from the prior year.
  • Cash from Financing Activities hit $19.6 million in Q4 2025 for ClearPoint Neuro, down from $32.0 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $46.9 million in Q1 2021 to a low of -$10.1 million in Q3 2024.
  • Historically, Cash from Financing Activities has averaged $5.5 million across 5 years, with a median of $155000.0 in 2023.
  • Biggest YoY gain for Cash from Financing Activities was 321160.0% in 2024; the steepest drop was 10956.04% in 2024.
  • Year by year, Cash from Financing Activities stood at $48000.0 in 2021, then soared by 362.5% to $222000.0 in 2022, then crashed by 30.18% to $155000.0 in 2023, then plummeted by 76.13% to $37000.0 in 2024, then surged by 52775.68% to $19.6 million in 2025.
  • Business Quant data shows Cash from Financing Activities for CLPT at $19.6 million in Q4 2025, $32.0 million in Q2 2025, and -$1.4 million in Q1 2025.